- Home
- ATOS vs BTLN Comparison
ATOS vs BTLN Comparison
Compare ATOS & BTLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.40
N/A
Current Price
$0.92
Company Overview
Basic Information| Metric | ATOS | BTLN |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 20.3M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATOS | BTLN |
|---|---|---|
| Price | $2.40 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 54.9K | ★ 89.6K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.88 |
| 52 Week High | $7.56 | $1.03 |
Technical Indicators
Market Signals| Indicator | ATOS | BTLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 30.97 |
| Support Level | $2.32 | $0.88 |
| Resistance Level | $2.60 | N/A |
| Average True Range (ATR) | 0.13 | 0.08 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 34.73 | 33.16 |
Price Performance
Historical Comparison ATOS
BTLN
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.